Paige AI

Paige AI develops AI technology specifically for cancer care, focusing on pathology workflows and molecular biomarker discovery from tissue samples. The company provides diagnostic AI applications that assist in cancer detection, subtyping, and biomarker identification using H&E-stained whole-slide images.

Paige AI is designed for pathologists and life sciences organizations, including those in clinical diagnostics, research, and drug development. Its tools support cancer detection, classification, and biomarker discovery to improve diagnostic efficiency and accuracy.

Paige offers foundation models such as Virchow, Virchow2, Virchow2G, and PRISM, which are trained on large datasets of tissue samples. These models power diagnostic applications and can be licensed for custom AI development in computational pathology.

Paige provides specialized AI suites for prostate, breast, gastrointestinal, and pan-cancer applications. These include tools like Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige PanCancer Suite, all designed to assist pathologists in cancer detection and diagnosis.

Paige Alba is a multi-modal co-pilot that integrates AI with voice and text commands to streamline pathology workflows. It provides real-time insights and optimized workflows to support cancer detection and diagnosis, built on Paige’s diagnostic and biomarker applications.

Yes, Paige offers custom AI development services, including the development of prognostic or predictive applications, regulatory strategy, and commercialization support. Organizations can license Paige’s foundation models to build tailored AI solutions for their research and development goals.